每经AI快讯,2月27日,君实生物发布业绩快报,2024年度公司实现营业总收入19.48亿元,同比增长29.67%;归属于母公司所有者的净亏损12.82亿元,去年同期净亏损22.83亿元。报告期内营业利润、利润总额、归属于母公司所有者的净利润、归属于母公司所有者的扣除非经常性损益的净利润、基本每股收益、加权平均净资产收益率较去年同期亏损减少,主要系公司积极落实“提质增效重回报”行动方案,持续加强...
Source LinkDisclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.